Stay updated on Durvalumab and Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.

Latest updates to the Durvalumab and Daratumumab in MM Clinical Trial page
- Check6 days agoChange DetectedThe page now displays a recruitment status note stating recruitment has ended, and adds new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study, along with a formatting change to the Intervention/Treatment label. Additionally, the revision tag has been updated to Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.3%

- Check14 days agoChange DetectedThe page's metadata was updated to include related topics like 'Multiple myeloma' and 'MedlinePlus Genetics' and to bump the revision from v3.5.4 to v3.5.5. This reflects ancillary information displayed with the study details rather than substantive changes to study data.SummaryDifference0.1%

- Check21 days agoChange DetectedThe related topics section no longer lists 'Multiple myeloma' and the 'MedlinePlus Genetics' entry, reducing links to disease context and a genetics resource.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new published version of the page. This reflects editorial or technical updates rather than changes to trial details.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page, expanding cross-references to disease terminology and genetics resources.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page’s footer has updated to the latest site revision (v3.5.3). Some generic “related topics”/topic listing text (including MedlinePlus-related items) was removed.SummaryDifference0.1%

Stay in the know with updates to Durvalumab and Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.